The efficacy of extrafine beclomethasone dipropionate–formoterol fumarate in COPD patients who are not "frequent exacerbators": a post hoc analysis of the FORWARD study

The efficacy of extrafine beclomethasone dipropionate–formoterol fumarate in COPD patients who are not "frequent exacerbators": a post hoc analysis of the FORWARD study

Dave Singh,1 Stefano Vezzoli,2 Stefano Petruzzelli,2 Alberto Papi3 1Medicines Evaluation Unit, University of Manchester, Manchester, UK; 2Chiesi Farmaceutici SpA, Parma, 3Section of Respiratory Diseases, University of Ferrara, Ferrara, Italy Abstract: The GOLD 2017 strategy document recommends tha...

Full description

Bibliographic Details
Main Authors: Singh D, Vezzoli S, Petruzzelli S, Papi A
Format: Article
Language:English
Published: Dove Medical Press 2017-11-01
Series:International Journal of COPD
Subjects:
COPD
GOLD B
GOLD 2017
Exacerbations
Corticosteroid
Online Access:https://www.dovepress.com/the-efficacy-of-extrafine-beclomethasone-dipropionate-formoterol-f-peer-reviewed-article-COPD

Internet

https://www.dovepress.com/the-efficacy-of-extrafine-beclomethasone-dipropionate-formoterol-f-peer-reviewed-article-COPD

Similar Items